Public filings / PBLS on Yahoo Finance (opens in a new tab)
PBLS: insider buying, 13F holders, analyst moves
Parabilis Medicines Inc - US
A summary of public filings about Parabilis Medicines Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold PBLS
Combined reported value $923.1M.
Holders among our 100 managers: 0 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $791.9M | 6.88% | New |
| Farallon Capital | $64.8M | 0.38% | New |
| Deerfield Company | $51.5M | 0.54% | New |
| Baker Bros. Advisors | $13.7M | 0.07% | New |
| Tudor Investment | $1.2M | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.